4/4/2024Rohto and Mitsui to Buy TCM Company for $590M

4/1/2024CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...

2/5/2024CMS Licenses Greater China Rights of First-line Phosphate-lowering Dru...

1/23/2024Chinese TCM Institutions Provided Diagnosis and Treatment to 1.28B Peo...

10/30/2023CDE Solicits Comments on the Technical Guidelines for Stability Study ...

10/24/2023CDE Solicits Comments on the Technical Guidelines for Clinical R&D of ...

10/18/2023CDE Issues the Technical Guidelines for Pharmaceutical Research of New...

8/24/2023CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...

3/30/2023Rxilient and Junshi form JV to Develop and Commercialize Toripalimab i...

2/14/2023NMPA Issues the Special Rules for TCM Registration

12/22/2022CDE Issues Two New Guidelines for Clinical Evaluation of New TCMs

12/5/2022Incyte Forms Partnership with CMS for Ruxolitinib Cream in Greater Chi...

11/11/2022NMPA Solicits Comments on the Special Rules for TCM Registration

9/27/2022CDE Solicits Comments on Two Draft Guidelines on TCM Registration

5/10/2022NMPA Issues Two Guidelines for TCM Registration and Evaluation

3/11/2022CDE Solicits Comments on Two Draft TCM Registration Guidelines

1/7/2022CDE Issues the Technical Guidance for Research of New TCM Toxicology S...

9/22/2021China-based CMS Joins BaseLaunch as Latest Partner

3/25/2021Shanghai Passes Law to Facilitate Traditional Chinese Medicine

3/12/2021CDE Issues the Guidelines for Acceptance and Evaluation of TCM Changes

2/5/2021CMS Acquires Dermatology Specialty Firm Luqa

1/15/2021CDE Issues the Technical Guidelines for Quality Studies of TCM New Dru...

12/17/2020CDE Issues the Technical Guidelines for Biological Effect Detection St...

11/10/2020CDE Issues the Pharmaceutical Dossiers Requirements for Communication ...

10/22/2020CDE Issues the Guidance for Acceptance and Evaluation of TCMs

9/28/2020NMPA Issues the Registration Classification and Dossier Requirements o...

8/21/2020Sun Pharma and CMS Enter into License Deal for Tildrakizumab in Greate...

6/4/2020Beijing Plans to Criminalize Criticisms of Traditional Chinese Medicin...

4/30/2020NMPA Solicits Comments on Six Draft TCM Registration Rules

1/20/2020Zydus and CMS enter into a License Agreement for Desidustat in Greater...

Page:1/4 Total number of articles:102: [First][<<] [1] [2] [3] [4] [>>] [End]